Patents by Inventor Yolanda CÁMARA NAVARRO

Yolanda CÁMARA NAVARRO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MITOCHONDRIAL DISEASES
    Publication number: 20250099473
    Abstract: The present invention provides a composition comprising one or more deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion and/or multiple deletions syndrome provided that the syndrome is not caused by a defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use of the invention there is a recovery in mitochondrial DNA levels independently from the severity of the patient's disease, which confers a great therapeutic value to the invention.
    Type: Application
    Filed: May 1, 2024
    Publication date: March 27, 2025
    Inventors: Ramon MARTÍ SEVES, Emiliano GONZÁLEZ VIOQUE, Cora BLÁZQUEZ BERMEJO, Javier TORRES TORRONTERAS, Raquel CABRERA PÉREZ, Yolanda CÁMARA NAVARRO
  • Treatment of mitochondrial diseases
    Patent number: 11998551
    Abstract: The present invention provides a composition comprising one or more deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion and/or multiple deletions syndrome provided that the syndrome is not caused by a defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use of the invention there is a recovery in mitochondrial DNA levels independently from the severity of the patient's disease, which confers a great therapeutic value to the invention.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: June 4, 2024
    Assignees: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA, CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED
    Inventors: Ramon Martí Seves, Emiliano González Vioque, Cora Blázquez Bermejo, Javier Torres Torronteras, Raquel Cabrera Pérez, Yolanda Cámara Navarro
  • TREATMENT OF MITOCHONDRIAL DISEASES
    Publication number: 20230060544
    Abstract: The present invention provides a composition comprising one or more deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion and/or multiple deletions syndrome provided that the syndrome is not caused by a defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use of the invention there is a recovery in mitochondrial DNA levels independently from the severity of the patient's disease, which confers a great therapeutic value to the invention.
    Type: Application
    Filed: April 25, 2022
    Publication date: March 2, 2023
    Inventors: Ramon MARTÍ SEVES, Emiliano GONZÁLEZ VIOQUE, Cora BLÁZQUEZ BERMEJO, Javier TORRES TORRONTERAS, Raquel CABRERA PÉREZ, Yolanda CÁMARA NAVARRO
  • Treatment of mitochondrial diseases
    Patent number: 11337980
    Abstract: The present invention provides a composition comprising one or more deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion and/or multiple deletions syndrome provided that the syndrome is not caused by a defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use of the invention there is a recovery in mitochondrial DNA levels independently from the severity of the patient's disease, which confers a great therapeutic value to the invention.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: May 24, 2022
    Assignees: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA, CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED
    Inventors: Ramon Martí Seves, Emiliano González Vioque, Cora Blázquez Bermejo, Javier Torres Torronteras, Raquel Cabrera Pérez, Yolanda Cámara Navarro
  • TREATMENT OF MITOCHONDRIAL DISEASES
    Publication number: 20180161332
    Abstract: The present invention provides a composition comprising one or more deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion and/or multiple deletions syndrome provided that the syndrome is not caused by a defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use of the invention there is a recovery in mitochondrial DNA levels independently from the severity of the patient's disease, which confers a great therapeutic value to the invention.
    Type: Application
    Filed: June 3, 2016
    Publication date: June 14, 2018
    Inventors: Ramon MARTÍ SEVES, Emiliano GONZÁLEZ VIOQUE, Cora BLÁZQUEZ BERMEJO, Javier TORRES TORRONTERAS, Raquel CABRERA PÉREZ, Yolanda CÁMARA NAVARRO